CALCIMEDICA, INC.
Profile
Company Names
CALCIMEDICA, INC.
GRAYBUG, INC.
GRAYBUG VISION, INC.
GRAYBUG LLC
Addresses
505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA 92037
275 SHORELINE DRIVE, SUITE 450, REDWOOD CITY, CA 94065
303 TWIN DOLPHIN DRIVE, SUITE 600, REDWOOD CITY, CA 94065-1422
6411 BECKLEY STREET, BALTIMORE, MD 21224
855 N. WOLFE STREET, GROUND FLOOR SUITE B, BALTIMORE, MD 21205
400 NORTH BROADWAY, STE 6013, BALTIMORE, MD 21231
35 WARRENTON ROAD, BALTIMORE, MD 21210
1340 SMITH AVENUE, SUITE 200, BALTIMORE, MD 21209
Phone Numbers
858-952-5500
443-853-2377
650-487-2800
410-614-9852
410-779-1236
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2011
State Incorporated:
MARYLAND
Total Amount Raised:
$144,808,735.00
Number of Funding Rounds:
8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2023-03-20
$9,109,912.00
$9,109,912.00
$0.00
Equity
7
2019-07-31
$54,999,994.00
$79,999,992.00
$24,999,998.00
Equity
6
2016-04-29
$75,393,829.00
$80,393,829.00
$5,000,000.00
Equity
5
2015-12-11
$750,000.00
$1,000,000.00
$250,000.00
Debt
4
2015-02-19
$1,740,000.00
$1,740,000.00
$0.00
Equity
3
2014-08-21
$750,000.00
$1,325,000.00
$575,000.00
Equity
2
2013-09-03
$1,455,000.00
$2,000,000.00
$545,000.00
Equity
1
2011-10-24
$610,000.00
$1,000,000.00
$390,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
GERALD
CAGLE
DIRECTOR
JEFFREY
CLELAND
DIRECTOR, EXECUTIVE OFFICER
EMMETT
CUNNINGHAM
DIRECTOR
DANIEL
GEFFKEN
EXECUTIVE OFFICER
SYNLOGIC, INC.
| LYSOSOMAL THERAPEUTICS, INC.
| OPSONIX, INC.
| APELLIS PHARMACEUTICALS, INC.
| ARCTURUS THERAPEUTICS LTD.
| VEDANTRA PHARMACEUTICALS, INC.
| SG DAN HOLDINGS LLC
| ELICIO THERAPEUTICS, INC.
| WINDTREE THERAPEUTICS INC /DE/
| PROMIS NEUROSCIENCES INC.
| CALCIMEDICA SUBSIDIARY, INC.
| CALCIMEDICA, INC.
FREDERIC
GUERARD
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
JUSTIN
HANES
DIRECTOR, EXECUTIVE OFFICER
CHAU
KHUONG
DIRECTOR
CERAPEDICS INC
| AERPIO THERAPEUTICS, INC.
| INSPIRE MEDICAL SYSTEMS, INC.
| PIERIS PHARMACEUTICALS, INC.
| SYNLOGIC, LLC
| AERPIO PHARMACEUTICALS, INC.
| SYNLOGIC, INC.
| SYNLOGIC, INC.
| PERFUSE THERAPEUTICS, INC.
| GRAYBUG VISION, INC.
| NOCTRIX HEALTH, INC.
| GENNAO BIO, INC.
| RESTORA MEDICAL, INC.
A.
RACHEL
LEHENY
EXECUTIVE OFFICER, DIRECTOR
FRED
MIDDLETON
DIRECTOR
MICHAEL
O-ROURKE
EXECUTIVE OFFICER, DIRECTOR
ERIC
W.
ROBERTS
EXECUTIVE OFFICER, DIRECTOR
CHRISTY
SHAFFER
DIRECTOR, EXECUTIVE OFFICER
CLINIPACE INC
| EVOAPP, INC.
| CLEARSIDE BIOMEDICAL, INC.
| G-ZERO THERAPEUTICS, INC.
| G1 THERAPEUTICS, INC.
| KINODYN, INC.
| SPYRYX BIOSCIENCES, INC.
| HATTERAS VENTURE PARTNERS V, LP
| GRAYBUG, INC.
| TREFOIL THERAPEUTICS, INC.
| GRAYBUG VISION, INC.
| ARTIZAN BIOSCIENCES, INC.
| PERFUSE THERAPEUTICS, INC.
| HATTERAS VENTURE PARTNERS VI, LP
| AER THERAPEUTICS, INC.
| HATTERAS VENTURE PARTNERS VII, LP
| HATTERAS OPPORTUNITY FUND I, LP
| HATTERAS CREATE SF SPV, LLC
ALLAN
SHAW
DIRECTOR
CAMERON
WHEELER
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-03-20
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE

